The market during the second quarter of 2019 continued to move upwards, yielding moderate returns for the quarter. The trade war with China continues to be a cause for caution, and Hong Kong protesters shut down a bill allowing extradition of Hong Kong citizens to the mainland. Finally, fears of recession loom, but ample liquidity tells us that there may not be cause for concern.
- Second Quarter Market Overview
- M&A Atmosphere
- Top M&A Transactions
- Zayo Group acquired by Digital Colony
- Clarios acquired by Brookfield Asset Management
- Array BioPharma acquired by Pfizer (NYS: PFE)
Click to download our General Quarter 2 2019 Mergers & Acquisitions Update
After just receiving knee replacement surgery, you begin to hike the Rocky Mountains. After you reach Pikes Peak, you take off your Virtual Reality glasses, and take a break from your rehabilitation in the health center. Is this the plot line to Ernest Cline’s book Ready Player One, or upcoming implementations of Virtual Reality in healthcare?
We cover a few trends we are seeing in Virtual Reality (VR) and Augmented Reality (AR), including surgical training, therapies, and patient engagement. In our attached white paper, we highlight:
- A History of VR/AR
- VR/AR Investment Activity
- VR/AR Healthcare Companies
- Potential VR/AR use cases
Download our Virtual Reality in Healthcare Whitepaper